Etern Therapeutics
- Biotech or pharma, therapeutic R&D
ETERN Therapeutics has developed an innovative liquid-liquid phase separation (LLPS) based HTS discovery engine targeting "undruggable"proteins. We are actively seeking partnership on our PCC~IND stage assets in Oncology, Immunology, Dermatology and Ophthalmology. We also seek early-stage R&D collaboration in development of molecules targeting "undruggable"proteins and diseases using LLPS platform.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}